Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC
Clinical trial NCT07459296 · RECRUITING
Trial details
- NCT number
- NCT07459296
- Sponsor
- First Affiliated Hospital of Guangxi Medical University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-05
- Primary completion
- 2030-04-01
- Enrollment
- 266
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.